New preclinical findings highlight Telomir-1’s ability to reverse CDKN2A gene silencing by DNA methylation, reactivating this gene – often called the body’s natural “cell cycle brake.” These results ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback